The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'March, 2017'. If you still can't find what you are looking for, try using the search box.
Abingdon, UK - Patient Status Engine and Lifetouch™ ‘smart bandage’ technology has now monitored more than 1,000 patients in a ground-breaking project transforming the way young patients are cared for. A ground-breaking project at Birmingham Children’s Hospital using wireless technology to predict deterioration in seriously ill children has recruited its 1,000th patient.
Read the rest of entry »
Abingdon, UK: Isansys Lifecare, the market leader in new generation wireless patient monitoring technology and patient digitisation systems and services, today announced the hiring of Sam Thwaites as its new UK Sales Manager, reporting to CEO Keith Errey.
Abingdon, UK - AMSBIO has published a new 36-page catalogue that details its comprehensive range of high purity reagents for proteoglycan and glycosaminoglycan research.
Abingdon, UK – Isansys Lifecare, a digital healthcare company developing an innovative patient monitoring platform which enables the early detection of deterioration in patients, today announces that the European Patent Office has accepted for grant a key method patent. The patent relates to the wireless wearable sensor technology incorporated in the Patient Status Engine (PSE), a CE-marked, Class IIa, continuous multiple vital sign patient monitoring platform.
Philadelphia, USA – Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) will be sharing its specialist Serialization expertise at the upcoming 3rd Anti-Counterfeiting Pharma conference (London Kensington Forum, March 7-8).
Oxford, UK – Immunocore Limited, a world-leading biotechnology company developing novel TCR-based biological drugs to treat cancer, infectious diseases and autoimmune diseases, announced today that it will present at the Cowen and Company 37th Annual Healthcare Conference in Boston, MA.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.